chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting approximately 8 hours after the shot, I experienced a mild allergic reaction (swollen eyelids and face, elevated heart rate, and mild difficulty breathing/throat closing up). I took a shot of asthma inhaler and nasal decongestant, and the symptoms resolved within 24 hours.
Muscle spasms arms, legs, face - 3 hrs nausea weakness falls asleep most of the time.
Developed large red swollen area and raised and very painful which lasted for 1 and 1/2 week. Area was about 8 inches x 4 inches wide.
Developed rash with tiny red bumps around neck and down back to buttocks.  Rash appeared itchy - patient would rub her head into neck to itch.
Body temp.: 9:00 pm, 02/27/2021: 99.7 f; 12:30 pm, 02/28/2021: 100.3 f; 1:50 pm, 02/28/2021: 100.6 f; 4:00 pm, 02/28/2021: 100.0 f; 8:00 pm, 02/28/2021: 99.7 f; 07:30 am, 03/01/2021: 94.9f; 10:30 am, 03/01/2021: 97.5 f
Patient and mom attended school vaccine event on 6/8. Mom requested patient to receive Janssen vaccine.  Nursing staff did not redirect to Pfizer based on patient age and administered the Janssen vaccine.  Patient waited 15 min of observation and then left with mom.  Later in the evening when paperwork was being sorted, the error was discovered.  As the supervisor of the team I was notified.  I called and spoke with mom around 7pm.  No side effects or issues with the patient currently.  Instructed to watch him overnight and I would follow up in the morning.  This morning I spoke with mom and learned that at 2300 patient complained of light headedness and body aches.  At 0345 woke up with a headache that was treated
started feeling joint pain at knee area; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (started feeling joint pain at knee area) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-May-2022, the patient experienced ARTHRALGIA (started feeling joint pain at knee area). At the time of the report, ARTHRALGIA (started feeling joint pain at knee area) outcome was unknown.            No concomitant medications were provided.  On 15-May-2022 around 4 pm, Patient received the 2nd booster dose.  On 16-May-2022 around evening 8 pm, Patient was totally okay until yesterday and started feeling joint pain at knees.  No treatment medications were provided.   Reporter did not allow further contact
This spontaneous report as received from a nurse refers to a 23 months 16 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) PEDVAXHIB injection, lot # K016965, exp. date: 20-JUL-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
This spontaneous report as received from nurse refers to a patient of unknown age and gender. On 23-SEP-2014, the patient was vaccinated with an expired dose of MMR II, 0.5 ml dose, subcutaneous, lot # H017027 and expiration date 14-SEP-2014. No adverse effect reported. Additional information has been requested.
blood clot; This is a spontaneous report from a Pfizer-sponsored program COVAX Support. A non-contactable consumer reported for a male patient. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical and concomitant medication history were reported. It was mentioned that caller has a 1st dose schedule tomorrow (31Jul2021) for COVID-19 vaccine. Caller asking if blood clot was a potential risk once caller got the vaccine. Caller stated that, her uncle got the 1st dose and after the vaccine a few days later he experienced a blood clot. Caller refused to provide any information about patient (uncle). The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch can not be obtained.
large local reaction ( 10 cm +) at injection site. Starting later in evening now at day 2 with axillary lymphadenopathy.  Chills, fever and muscle aches starting late evening after injection for <24 hrs.
Case completed his Covid vaccine series in APril 2021, then was admitted to  hospital in September 2021 for treatment os Covid
4-6 hours after injection, left thigh (^) redness and swelling area, approximately 15cm x 10cm.  Baby was noticeable more fussy and irritable the last 2 days parents call 06/13/2003 @ 10:30 to report findings.  Advised ibuprofen, cool packs to area child is using limb.
8/2/02 fever 101.7 ax. 8/3/02 fever. Did get sl. rash on 8/5/02 reports doing well. No rash. No vomiting. Tylenol drops 1 1/2 dropper Q 4-6 hours.
1/11/15 pt went to doctor with hives and headache.  She returned to Dr on 1/13/15 with pharyngeal swelling and was treated with epinephrine, Decadron and Benadryl.
Sore arm, body aches, headache, sweating, weakness 14 hours after shot.
Mother states second of series of three vaccines, daughter complainted of pain in arm with difficulty with movement from day of vaccine to current time.  Mother states daughter did not experience same symptoms either with first nor third vaccine in series.
Patient reported noticing redness around the injection site, some itching, and warmth to the touch. She also mentioned the redness was raised and blanchable. She used Benadryl and hydrocortisone cream to relieve the itching/ discomfort. She stated that the redness and symptoms lasted for a week. She did not report this to our clinic till she was due for her second dose a month later. She still has a red oval on her left arm.
given 2nd dose from a vial that was just thawed but technically expired last night at 2359.
Moderna 1st vacs, = Fatigue and Sore Arm of the injection site. 30 days later got the second vaccine. Moderna 2nd - vacs = Raging Headache, Severe Chills, Major Fatigue, Nausea - no vomiting.  This lasted a total of 48 hours. My body ached and I felt like I did not own my body anymore. Flu-like symptoms. Major bowel movement after 48 hours and then I felt Normal.
Pt was administered ZOSTVAX instead of VARIVAX. Called Merck and the stated I needed to report to VAERS.
Narrative:  Completed Pfizer 2 dose COVID19 vaccination on 2/25/21. Presented to ER on 7/18/21 with one day of lightheadedness and cough. New onset afib and COVID + test. Patient declined hospital admission and was d/c the same day. Patient presented to ER again on 7/24/21 due to continued fever, myalgias, and "generally feeling bad". O2 saturation dropped to 88% and troponins were slightly elevated. Diagnosed with COVID pneumonia Admitted with supplemental O2 and dexamethasone 6mg daily initiated. COVID supportive care and oxygen provided during hospitalization. Discharged 8/2/21 with guaifenesin, benzonatate, and methylprednisolone dose pack. Multiple comorbidities including CHF, cardiac defibrillator/pacemaker placement DM, PVD, CAD, MI, ESRD on hemodialysis, obesity, COPD, and microvascular DM complications.
**Tingling in my tongue immediately after the shot--lasted about an hour then turned into a light metallic taste in my mouth that lingers still  **Debilitating headache for first 24 hours  **Ringing in my ears since Monday evening
Site: Swelling at Injection Site-Medium, Additional Details: The patient noticed vesicles, blisters at the site.  No swelling noted. He took bandage off.  He denied itch.
One and 1/2 days after vaccination (L) arm red and swollen from shoulder to elbow, no pain, able to move freely, itchy. Doctor notified. Mom brought child to health dept. to report reaction, child took MOTRIN and BENADRYL. Redness and swelling greatly reduced 5 days after vaccination. Child afebrile entire course of episode.
Information has been received form a RN concerning a 6 year old Caucasian female pt who on 01/15/1999 was vaccinated SQ with 2nd 0.5ml dose of varicella virus vaccine, live. There  was no illness at the time of vaccination. There were no concomitant therapies. On 05/27/04, the pt started to breakout with some spots. By 05/28/2004, the spots covered her entire body and there was lots of itching. On 05/28/2004, the pt was seen in the office to verify chickenpox. The pt had widespread red papules and clear vesicles on red bases. Several of the lesions had central crusting. The pt was diagnosed with chickenpox. RX drug tx was not required. On 06/06/04, the pt recovered. Additional information is not requested.
HPV given client states "I Feel Dizzy". Client falls backward into chair. Eyes roll backward into lids, body becomes stiff and rigid. Then jerking rhythmical movement starts.
patient has a prescription for Shingrix and was informed by his doctor that he only needed one dose; This case was reported by a pharmacist via call center representative and described the occurrence of off label use in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced off label use. On an unknown date, the outcome of the off label use was unknown.  Additional details were provided as follows: The age at vaccination was not applicable.  The first dose was not administered because the pharmacist had questions about only administering one dose as the doctor had it written for only one dose. The pharmacist stated that, the patient had a prescription for Shingrix and was informed by his doctor that he only needed one dose, which led to off label use. The reporter asked was there any information on this. The reporter filling proactively as there might be a possible underdose for this patient since the Medical Doctor wrote a prescription for only one dose.  No additional details were available and no permission for follow up as decision to file adverse event was made after the call was completed. The first dose was not administered because the pharmacist had questions about only administering one dose as the doctor had it written for only one dose. The reporter stated that, he or she filed the adverse event proactively since the doctor wrote the prescription for one dose
one dose 2-3 years ago, did not follow up with second; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix  (received first dose 2 to 3 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 1-Nov-2022 Reporter's comment: The reporter asked that if the patients had one dose of 2 to 3 years ago, but did not follow-up with the second one, should they start all over or just receive one more dose. This was a chat question, asked for demographics and the chatter declined and then abandoned the chat. Additional supportive information: Till the time of reporting, the patients did not receive second dose of Shingrix, which led to incomplete course of vaccination.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A 23-month-old male patient received the fourth dose of PREVNAR 13 on an unknown date. Relevant medical history included Down Syndrome. The patient was hospitalized on an unknown date due to pneumococcal disease (type unknown). The physician suspected it could be bacteremia. Therapeutic measures taken as a result of the event were unknown. The patient was discharged on an unknown date. The outcome of the event was unknown.
patient stated she had an allergic reaction to ibuprofen that caused difficulty breathing.  I had patient wait an additional 10 minutes and patient left observation stating she felt fine.  Patient returned after shopping and stated she felt a pressure in her chest.  The patient denied nausea, sweating, itching, and any other sensation.  I took the patients blood pressure and it was 121/71.  Patient waited under observation for another 10 minutes and then left saying she felt fine
Uncertain if truly caused by the vaccine.  I had an ACL reconstruction done back in May of 2020.  My knee has transient swelling that comes and goes, but is not particularly frequent.  3 days after receiving the vaccine, my knee swelled up and remained swollen for about 7 days.  It has since gone back down.  I did not have any acute injuries or remarkable events happen during this time other than the vaccine administration.  Overall, uncertain if it was caused by vaccine, but it was odd enough to report.
On January 21, 2021 at the Clinic, a PA was administering vaccinations during the morning for a four-hour shift, 8 AM to noon. At the end of her shift, she handed off her vaccines to another vaccinator. The PA had three doses of vaccine drawn up at that time, in syringes, on her desk. When the RN inspected the syringes, she found 0.4mL of vaccine had been drawn into those syringes rather than the required 0.3mL. The RN then alerted the APRN, who escalated the situation to the manager. The manager then contacted Quality. The concern was that the PA had been vaccinating patients all morning with an inappropriate dose of vaccine, 0.4mL. After thorough internal investigation, we found that the PA drew up 38 vaccine doses and administered 35 of them. Additionally, based on vial usage for the day and total number of vaccines administered, we have concluded that it is highly unlikely that excess vaccine was administered. This was a near miss event and is being reported out of an abundance of caution.
Chills and fever within 3 hours of vaccination, temperature reached 101 degrees F.  Sore arm but no swelling or redness at site.  No upper respiratory symptoms.  Dull headache, body aches.  No GI problems or rash.  Temperature normal this morning at 7 AM.  Body aches gone, but still has headache and feels "blah".
Information has been received from a physician concerning a 5 year old who was vaccinated with a dose of varicella virus vaccine live at one year of age. There were no concomitant medication. The reporter noted that the vaccination was received at another facility and no lot number or date of vaccination was available. On 08/01/04 the pt developed a relatively mild case of chickenpox. Unspecified medical attention was sought and no medication was given. The physicain noted that she did not refer to this breakthrough. It was also indicated that the pt was originally seen by a physician on 08/02/2004 and then for followup  on 08/04/2004 when the pt was reported to look much better. AT the time of the report, the pt was recovering. A product quality complaint was not involved. Follow up information information was recieved form the physician who indicated that on approximately 06/30/04 the pt had an outbreak of fairly classic varicella. On 08/02/2004, the pt  was seen with classic varicella and no evidence of secondary infection. There were noted to be greater than 50 lesions. The pt was seen again the following day with continued resoulution of the rash and drying . The pt was reported to be exposed at a daycare setting where at least five other children had chicken pox as well. The other children had also been vaccianted per the daycare report. No diagnostic or laboratory tests were performed. Subsequently, the pt recovered. No further information is expected. The physician also reported five other children who developed  chickenpox after therapy with varicella virus vaccine live.
"Covid Arm", left arm red, warm to touch, swollen. Soft ball size erythema tender and warm to touch. Striae distal to this. Localized myalgia. Temp 99.1.
nausea, patient felt "hot inside" Narrative:  10 min after 1st dose moderna COVID19 shot pt felt nauseated, was pale/diaphoretic SpO2-93 on 2 L O2, retching. Patient felt very hot. Pt improved during monitoring. VVS normalized SpO2-95/RA, refused paramedic transport to ED. 3/19/21 EKG NSR. Resolved completely. no reaction with recent flu/pn shots. Patient then felt fine for 2 days, but per patient 3/22/21 felt fatigued, then had 101 temp 3/23/21. no HA/myalgias, but B arms sore. Defervesced after tylenol. History: Pt had the same "hot" feeling 2 days prior to the vaccination, lasted 10 min. In past had daily, less often now 3/month, no ID'd triggers. Pt feels comfortable getting 2/2 COVID19 vaccination.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot#J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share with Merck.  Follow up information has been received from the registered nurse who provided patients details. This report refers to a 9 weeks old infant patient of unknown gender. On 03-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported, lot#J016188, expiration date 02-OCT-2014) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected.
mild chest tightness/hoarse throat 3 hours after vaccine No rash No swelling No trouble breathing.  No URI sx
Pt had a flu vaccine on 09/27/23 @ 16:00.  Approx. an hour after vaccine staff member stated to feel euphoric, experienced intense dizziness, and visions of bright trailing lights,   when turning his focus from (R) side to (L) side at 04:00 experienced severe diaphoresis clothing and bed were completely saturated. He then vomited x2. Feeling as if he had the worst hangover he has ever had. The next 24 hours consisted of elevated temperatures instantly following any consumption of food. Staff member had been educated at time of vaccine re: reporting adverse s/s.
Patient reported swollen lymph nodes under arm.  Has been treated for breast cancer 3 times.  Her doctor advised against getting 2nd dose.  She is still interested in getting a 2nd dose but maybe one of the others without many side effects.
Pt received Hep-B and Hep-A vaccines on 12/8/99, went on business trip to Asia. Pt reported to his PCP, that all joints were swollen since February 1, 2000.
Death 5 hours after second shot. Decedent contacted her mother around 3:30 c/o difficulty breathing. Died on 4/1/20
I had a little headache and was dizzy in the car and had diarrhea once but it wasn't bad; I had a little headache and was dizzy in the car and had diarrhea once but it wasn't bad; I had a little headache and was dizzy in the car and had diarrhea once but it wasn't bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), DIZZINESS (non-serious), DIARRHOEA (non-serious), outcome "unknown" and all described as "I had a little headache and was dizzy in the car and had diarrhea once but it wasn't bad".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
ED to Hosp-Admission: Discharged 4/9/2021 - 4/12/2021 (3 days) Admission Date: 4/9/2021 - Discharge Date: 4/12/2021- Presenting Problem/History of Present Illness/Reason for Admission- Intracranial mass [R90.0], Hyperglycemia [R73.9], Acute encephalopathy [G93.40], COVID-19 [U07.1]. COVID-19 infection: Despite patient's immunization history, patient did test positive for COVID-19 on presentation. She required supplementation with 2 L of oxygen to maintain oxygen saturations. Dexamethasone 6 mg daily and remdesivir were initiated and continued for four days. Patient did have mild sinus bradycardia (with heart rates in the 50s) towards the end of the hospitalization but remained asymptomatic. Oxygen was weaned to room air and patient remained stable for
he can't eat; feeling very sleepy; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). An 87-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose unknown via an unspecified route of administration on 09Feb2021 (at the age of 87 years old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included hypoacusis. Concomitant medication included tafamidis (VYNDAMAX) taken for an unspecified indication. Patient stated on an unspecified date in Feb2021, he took the covid vaccine yesterday and he can't eat and was feeling very sleepy. The outcome of the events was unknown.  Information on batch/lot number has been requested.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Numbness & tingling throughout body & weakness only treatment so far is being placed on steroids.
On day 2 after my second shot i had severe joint and back pain. Knees, ancles, wrists of both hands and lower left shoulder.   The pain in my knees and ancles seems to have gone away. Still have some light pain on right wrist and currently still continues daily pain on the left wrist and left shoulder.
Information has been received from a physician concerning a patient who on unspecified dates was vaccinated with all three doses of GARDASIL. Subsequently the patient had developed HPV. The physician stated that the patient's HPV was high risk. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. On an unspecified dates, unspecified number of patients were vaccinated with improperly stored PROQUAD lot # M035143, expiration 30-JAN-2018 (route and dosage not reported) for prophylaxis, reconstituted with sterile water diluent. Temperature excursion/ time frame: PROQUAD at -9 degrees Celsius to 8 degree Celsius for 5 hours 36 minutes, which was called by a data logger. No adverse effects were reported. This is one of two cases from the same patient. All telephone attempts to obtain follow-up information have been unsuccessful. Sender's Comments: US-009507513-1707USA004372.